Sir Run Run Shaw Hospital
Hangzhou, Zhejiang, 310000, China
Location status: Recruiting
NCT Number: NCT06633809
This multicenter registry study, which record the therapy strategy and follows up these acute ischemic stroke (AIS) patients with low NIHSS and large vessel occlusion (LVO), is intended to provide the important data for therapy evaluation and prognostic prediction of the LVO patients with low NIHSS.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Hangzhou, Zhejiang, 310000, China
Location status: Recruiting
It was reported that about two third of the stoke patients might present with minor or mild stroke symptoms. 20-40% of those minor stroke patients had large vessel occlusion (LVO). AIS patients with LVO and low NIHSS are common and has been associated with early neurological deterioration and worse outcomes. Until now, the best therapy strategy for the acute stoke patients with minor stroke and large vessel occlusion is unknown. Thus, we sought to (1) explore the potential predictors of acute neurological deterioration and 90-day clinical outcome; (2) and evaluate the best therapy strategy.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The best medical therapy includes intravenous fibrinolysis, anticoagulants or antiplatelet, but NOT any immediate endovascular therapies.
Other names: Best medical therapy
Time frame: 90 days
modified Rankin Scale at 90 days
Time frame: 24 hours
It is neurological deterioration of presumed ischemic origin with an NIHSS score increase of 4 points or more within the 24 hours after onset.
Time frame: 2-3 days
Incidence of symptomatic intracerebral hemorrhage according to ECASS II criteria
Time frame: 90 days
Good outcome is defined as a score of 0-2 on the 90-day mRS
Sir Run Run Shaw Hospital
Other
Therapy Evaluation in Patients With Minor Stroke and Large Vessel Occlusion: A Prospective Multicenter Registry Study
Acronym: TEMPOS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03994822
Brain Diseases, Brain Infarction
Scottsdale, Arizona, United States
View Trial DetailsNCT06418698
Brain Diseases, Cardiovascular Diseases
Guangzhou, Guangdong, China
View Trial DetailsNCT06121336
Brain Diseases, Brain Injuries
Munich, Bavaria, Germany
View Trial DetailsNCT04774510
Brain Diseases, Cardiovascular Diseases
Le Kremlin-Bicêtre, Kremlin-Bicêtre, France
View Trial Details